CO5011067A1 - Derivados de bifenilo como productos farmaceuticos, su pre- paracion y composiciones farmaceuticas que los contienen - Google Patents
Derivados de bifenilo como productos farmaceuticos, su pre- paracion y composiciones farmaceuticas que los contienenInfo
- Publication number
- CO5011067A1 CO5011067A1 CO98063635A CO98063635A CO5011067A1 CO 5011067 A1 CO5011067 A1 CO 5011067A1 CO 98063635 A CO98063635 A CO 98063635A CO 98063635 A CO98063635 A CO 98063635A CO 5011067 A1 CO5011067 A1 CO 5011067A1
- Authority
- CO
- Colombia
- Prior art keywords
- carbon atoms
- alkyl
- alkoxy
- hydrogen
- atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
La presente invención se relaciona con un compuesto de lafórmula I: en donde:R1 y R2 , independientemente, son hidrógeno, alquilo (de 1 a 4 átomos de carbono), alcoxi (de 1 a 4 átomos de carbono), tioalquilo (de 1 a 4 átomos de carbono), halógeno, trifluorometilo, trifluorometoxi, ciano ó alcanoílo (de 2 a 5 átomos de carbono), R3 es hidrógeno, hidroxi, alquilo (de 1 a 4 átomos de carbono), alcoxi (de 1 a 4 átomos de carbono), cicloalquiloxi (de 3 a 6 átomos de carbono), halógeno, ciano, alcanoílo (de 2 a 5 átomos de carbono), carbamoílo, alquilo (de 1 a 4 átomos de carbono)-sulfoniloxi o trifluorometilsulfoniloxi, R4 es hidrógeno, hidroxi ó alcoxi (de 1 a 4 átomos de carbono), y R5 es un grupo de la fórmula (a), (b), (c) ó (d)en donde: R6 es alquilo (de 1 a 4 átomos de carbono), X es una cadena de alquileno recta ó ramificada con 1 a 4 átomos de carbono, y R7 y R8 , independientemente, son hidrógeno, alquilo (de 1 a 4 átomos de carbono), hidroxialquilo (de 2 a 4 átomos de carbono), ó fenilalquilo (de 1 a 4 átomos de carbono), ó forman, junto con el átomo de nitrógeno con el que están unidos, un grupo pirrolidinilo, piperidino, piperazinilo ó morfolino, ó un grupo de la fórmula (e): en donde Z es O, CH2 ó CH2 -CH2 , y R9 , R10 , R11 , R12 , R13 y R14 , independientemente, son H, halógeno, alquilo (de 1 a 4 átomos de carbono), ó alcoxi (de 1 a 4 átomos de carbono), en forma de base libre ó de sal de adición de ácido.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9723134.4A GB9723134D0 (en) | 1997-11-03 | 1997-11-03 | Organic compounds |
GBGB9723133.6A GB9723133D0 (en) | 1997-11-03 | 1997-11-03 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5011067A1 true CO5011067A1 (es) | 2001-02-28 |
Family
ID=26312535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO98063635A CO5011067A1 (es) | 1997-11-03 | 1998-10-29 | Derivados de bifenilo como productos farmaceuticos, su pre- paracion y composiciones farmaceuticas que los contienen |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1037876A1 (es) |
JP (1) | JP2001521923A (es) |
KR (1) | KR20010031699A (es) |
CN (1) | CN1278249A (es) |
AR (1) | AR016148A1 (es) |
AU (1) | AU740448B2 (es) |
BR (1) | BR9813897A (es) |
CA (1) | CA2308151A1 (es) |
CO (1) | CO5011067A1 (es) |
ID (1) | ID24413A (es) |
IL (1) | IL135580A0 (es) |
NO (1) | NO20002321L (es) |
NZ (1) | NZ503815A (es) |
PE (1) | PE123599A1 (es) |
PL (1) | PL339922A1 (es) |
SK (1) | SK6412000A3 (es) |
TR (1) | TR200001122T2 (es) |
WO (1) | WO1999023073A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041280B2 (en) | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
US6858592B2 (en) | 2001-06-29 | 2005-02-22 | Genzyme Corporation | Aryl boronic acids for treating obesity |
TW200840566A (en) * | 2006-12-22 | 2008-10-16 | Esteve Labor Dr | Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
US8642583B2 (en) | 2008-10-30 | 2014-02-04 | Janssen Pharmaceutica Nv | Serotonin receptor modulators |
WO2010059390A1 (en) | 2008-10-30 | 2010-05-27 | Janssen Pharmaceutica Nv | Modulators of serotonin receptor |
DE102009015697A1 (de) | 2009-03-31 | 2010-10-07 | Markus Dr. Heinrich | Verfahren zur Arylierung von ringsubstituierten Phenolen und Phenylethern |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2114122A (en) * | 1938-04-12 | Alcohols and process fob making | ||
DE674968C (de) * | 1935-01-15 | 1939-04-26 | Roehm & Haas Company | Verfahren zur Herstellung von phenolartigen Aralkylaminoalkoholen |
US2040039A (en) * | 1935-02-26 | 1936-05-05 | Rohm & Haas | Phenolic morpholines |
US2485550A (en) * | 1946-06-25 | 1949-10-25 | Hoffmann La Roche | Quaternary salts of carbamic acid esters of tertiary-hydroxybenzyl-amines |
US2493710A (en) * | 1947-03-21 | 1950-01-03 | Hoffmann La Roche | Carbamic acid esters |
US2872477A (en) * | 1957-04-05 | 1959-02-03 | Dow Chemical Co | alpha-(dialkylamino)-6-phenyl-o-cresol esters |
JPS5328150A (en) * | 1976-08-25 | 1978-03-16 | Sugai Chemical Ind Co Ltd | Novel orthophenyl phenol derivative process for preparing same |
US5053548A (en) * | 1989-02-08 | 1991-10-01 | Otsuka Pharmaceutical Company, Ltd. | Biphenyl derivative composition for nerve cell degeneration repairing or protective agent and process for preparing a phenyl derivative contained in the composition |
US5428037A (en) * | 1993-04-09 | 1995-06-27 | Syntex Pharmaceuticals, Ltd. | Heterocyclic derivatives in the treatment of Ischaemia and related diseases |
JPH072655A (ja) * | 1993-06-18 | 1995-01-06 | Otsuka Pharmaceut Co Ltd | 末梢神経変性修復又は保護剤 |
PT707007E (pt) * | 1994-10-14 | 2002-06-28 | Merck Patent Gmbh | Derivados amino(tio)eter como agentes activos no snc |
MX9703671A (es) * | 1994-11-23 | 1997-12-31 | Neurogen Corp | Compuesto de aminometil arilo y ligandos selectivos del subtipo de receptor de la dopamina. |
IL116249A (en) * | 1994-12-12 | 2003-07-06 | Pfizer | Nk-1 receptor antagonists for the treatment of neuronal damage and stroke |
DE19637237A1 (de) * | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
-
1998
- 1998-10-29 CO CO98063635A patent/CO5011067A1/es unknown
- 1998-10-30 NZ NZ503815A patent/NZ503815A/en unknown
- 1998-10-30 JP JP2000518948A patent/JP2001521923A/ja active Pending
- 1998-10-30 AR ARP980105469A patent/AR016148A1/es not_active Application Discontinuation
- 1998-10-30 WO PCT/EP1998/006880 patent/WO1999023073A1/en not_active Application Discontinuation
- 1998-10-30 BR BR9813897-9A patent/BR9813897A/pt not_active IP Right Cessation
- 1998-10-30 SK SK641-2000A patent/SK6412000A3/sk unknown
- 1998-10-30 CN CN98810761A patent/CN1278249A/zh active Pending
- 1998-10-30 PL PL98339922A patent/PL339922A1/xx unknown
- 1998-10-30 TR TR2000/01122T patent/TR200001122T2/xx unknown
- 1998-10-30 IL IL13558098A patent/IL135580A0/xx unknown
- 1998-10-30 KR KR1020007004762A patent/KR20010031699A/ko not_active Application Discontinuation
- 1998-10-30 AU AU14872/99A patent/AU740448B2/en not_active Ceased
- 1998-10-30 ID IDW20000790A patent/ID24413A/id unknown
- 1998-10-30 CA CA002308151A patent/CA2308151A1/en not_active Abandoned
- 1998-10-30 EP EP98958884A patent/EP1037876A1/en not_active Withdrawn
- 1998-11-02 PE PE1998001034A patent/PE123599A1/es not_active Application Discontinuation
-
2000
- 2000-05-02 NO NO20002321A patent/NO20002321L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1278249A (zh) | 2000-12-27 |
NZ503815A (en) | 2002-05-31 |
CA2308151A1 (en) | 1999-05-14 |
AU1487299A (en) | 1999-05-24 |
TR200001122T2 (tr) | 2000-08-21 |
EP1037876A1 (en) | 2000-09-27 |
BR9813897A (pt) | 2000-09-26 |
PE123599A1 (es) | 1999-12-20 |
AU740448B2 (en) | 2001-11-01 |
NO20002321D0 (no) | 2000-05-02 |
ID24413A (id) | 2000-07-20 |
SK6412000A3 (en) | 2000-09-12 |
AR016148A1 (es) | 2001-06-20 |
WO1999023073A1 (en) | 1999-05-14 |
IL135580A0 (en) | 2001-05-20 |
JP2001521923A (ja) | 2001-11-13 |
PL339922A1 (en) | 2001-01-15 |
KR20010031699A (ko) | 2001-04-16 |
NO20002321L (no) | 2000-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR015649A1 (es) | Inhibidores de isoprenil-transferasas proteicas, composiciones que los comprenden y el uso de los mismos para la fabricacion de un medicamento | |
SV1998000008A (es) | Inhibisores de sulfamida-metaloproteasa. ref. ran 4070\114 | |
ES2187983T3 (es) | Derivados 1,2,3,4-tetrahidronaftaleno sustituidos. | |
AR061422A2 (es) | Peptidos ciclicos selectivos, procedimiento de preparacion, composicion farmaceutica que los comprende, y uso de los mismos en la preparacion de medicamentos | |
HUP0301514A2 (hu) | Benzimidazol származékok, elżállításuk és ezeket tartalmazó gyógyszerkészítmények | |
HUP0302468A2 (hu) | Alfa V integrin receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények | |
CO4900050A1 (es) | Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba | |
HU895609D0 (en) | Process for the preparation of novel 1,4-diazepine derivatives and pharmaceutical compositions containing such compounds | |
ES2059804T3 (es) | Procedimiento de preparacion de eteres de oxima de propenona. | |
CO5271675A1 (es) | Derivados de decahidro-isoquinolinas, proceso para su preparacion, composicion y compuestos farmaceuticos que los contienen | |
CO5031242A1 (es) | Derivados de cromanona y tiocromanona, proceso para su preparacion y composicion farmaceutica que los comprende | |
ATE175661T1 (de) | Benzamid-derivate als vasopressin-antagonisten | |
CO4980887A1 (es) | Nueva 3,4-diariltiazolina-2-uno o 2-tiono derivados, sus metodos de preparacion y su uso terapeutico | |
CO5011067A1 (es) | Derivados de bifenilo como productos farmaceuticos, su pre- paracion y composiciones farmaceuticas que los contienen | |
MX9306310A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
MY129176A (en) | Tetrahydro gamma-carbolines | |
DK0682015T3 (da) | Piperidinderivater og anti-blodplademidler indeholdende dem | |
EA200300044A1 (ru) | Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции | |
DE3676763D1 (de) | Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten. | |
ATE297918T1 (de) | Tetrahydropyridine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
CO5140091A1 (es) | Derivados de piperidina y piperazina, su preparacion, su uso como productos farmaceuticos y composiciones farmaceuticas que los contienen | |
ES2131549T3 (es) | Derivados macrolidas de 16 eslabones y su procedimiento de preparacion. | |
ECSP982725A (es) | Derivados de bifenilo | |
AR002259A1 (es) | Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion, compuestos intermedios y composicion que contiene a dichos derivados. | |
CO4940440A1 (es) | Cromanos novedosos de la formula i, su preparacion, su uso como productos farmaceuticos y composiciones farmaceuticas que los contienen |